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Hyperprolactinemia 
Background  
1. Definition  
o Prolactin level above normal (varies by lab) 
o Can be physiologic, drug-induced or pathologic 
2. Anterior pituitary secretes prolactin in response to input from hypothalamus 
(including thyrotropin releasing hormone) and has dopamine receptors  
o Dopamine inhibits release of prolactin from pituitary 
 
Pathophysiology 
1. Physiologic states  
o Pregnancy 
o Early nursing 
o Nipple stimulation 
o Stress 
o Sleep 
o Food 
o Sex 
2. Drugs - common cause of elevated prolactin  
o Dopamine receptor antagonists  
 Phenothiazines, metoclopramide, risperidone 
o Hormones  
 Estrogen, antiandrogens 
o Dopamine depleting agents  
 Methyldopa, reserpine 
o Opiates 
o Verapamil 
o SSRIs (rarely) 
3. Disease states  
o Pituitary tumors  
 Prolactinoma 
 Adenoma secreting growth hormone and prolactin 
 Adenoma secreting ACTH & prolactin 
 Nonfunctioning chromophobe adenoma with pituitary stalk 
compression 
o Hypothalamic/pituitary stalk dz  
 Granulomatous dz 
 Craniopharyngioma 
 Cranial XRT (previous radiation Tx) 
 Empty sella 
 Vascular aneurysm 
 Lymphocytic hypophysitis 
 Metastatic carcinoma 
o Primary hypothyroidism  
 Secondary to increased TRH production by hypothalamus 
o Chronic renal failure 
o Cirrhosis 
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o Chest wall trauma 
o Seizures  
 Elevated prolactin level sometimes used as marker of recent seizure 
4. Prevalence  
o 0.4% in general population (estimated) 
o Doesn't include most physiologic causes 
o Difficult to quantify due to lack of screening in patients on drugs that cause 
hyperprolactinemia less commonly 
5. Risk factors  
o Meds listed above, radiation, disease states listed above 
6. Morbidity  
o Headaches, infertility, visual loss (other symptoms listed below) 
7. Mortality  
o Very low 
 
Diagnosis 
1. History  
o Hx and physical exam can distinguish among most physiologic, 
pharmacologic, or pathologic causes of elevated serum prolactin level 
(SPL)  
o Women  
 Galactorrhea, amenorrhea, mass effects if pituitary overly large 
(HA, visual disturbance) 
o Men  
 Hypogonadism, decreased libido, impotence, infertility, mass effects 
if pituitary overly large (HA, visual disturbance)  
o Pearl  
 Hx and PE can distinguish among most physiologic, pharmacologic, 
or pathologic causes (SOR:C)
1
  
2. Physical exam  
o Breast tenderness, galactorrhea, visual defects, growth deficiency in 
children 
3. Testing  
o Serum prolactin (>1 hr after eating)  
 Some recommend fasting 
 Repeat if elevated and consider adding TSH, BUN, creatinine, HCG 
if indicated 
o Imaging  
 MRI or CT of sella turcica (consider if mass effects or prolactin 
>200 mcg/L (SOR:C)
1
  
 If negative imaging, could still have microadenoma 
 Macroadenoma is defined as >1 cm 
 
Differential Diagnosis  
1. Key differential diagnoses  
o Pregnancy 
o Lactation 
o Primary hypothyroidism 
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o Stress 
o Seizures 
o Chronic renal failure 
o Pituitary adenoma 
o Iatrogenic hyperprolactinemia  
2. Extensive differential diagnoses  
o See pathophysiology  
 
Therapeutics  
1. Acute treatment  
o Assess for mass effects, ensure adequate history and exam have been 
performed to guide further treatment 
o Stop offending drug if needed 
2. Further management  
o Physiologic  
 Expectant management 
o Drug-related  
 Stop drug 
 Watch for evidence of mass effect that might indicate incorrect 
diagnosis 
o Pathologic  
 Medical management  
 Bromocriptine (dopamine agonist) 
 Cabergoline (long acting dopamine agonist)  
o More effective and better tolerated than 
bromocriptine (SOR:B)
1
  
 Transphenoidal surgery/irradiation  
 Only if pt shows evidence of critical mass effects that require 
urgent treatment 
3. Long-term care  
o Physiologic  
 Expectant management  
 Monitor for symptoms of hypogonadism (amenorrhea, 
infertility, or sexual dysfunction) and have prolactin 
measured at intervals 
 Frequency of intervals depends on etiology and no clear EBM 
intervals noted 
o Drug-related  
 See further mgmt 
 If not responding to drug cessation, reconsider etiology 
 Consider dopamine agonists 
o Pathologic  
 See further mgmt 
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Follow-Up  
1. Return to office  
o Physiologic  
 Monitor for symptoms of hypogonadism (amenorrhea, infertility, or 
sexual dysfunction) and have prolactin measured at intervals 
o Drug-related  
 F/u and repeat lab testing if symptoms don't resolve with drug 
cessation, consider other etiologies 
o Pathologic  
 Regular f/u if unable to correct underlying condition, periodic 
prolactin levels (initially every 1-3 months) to ensure medical 
control 
o Recommendations for earlier follow-up  
 Mass effects, visual disturbance 
2. Admit to hospital only if severe mass effects, considering urgent surgery 
 
Prognosis  
1. Generally excellent, as long as cause identified and treatment initiated 
 
Prevention  
1. Caution patients about symptoms to watch for when starting agents that can cause 
hyperprolactinemia 
 
Patient Education 
1. American Society for Reproductive Medicine 
http://www.asrm.org/Patients/FactSheets/Prolactin_Excess.pdf Accessed 4.6.2009  
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Evidence-Based Inquiry 
1. What is the recommended evaluation and treatment for elevated serum prolactin? 
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